<!doctype html>
<html class="no-js" lang="">
<head>
  <meta charset="utf-8">
  <meta name="description" content="">
  <meta name="viewport" content="width=device-width, initial-scale=1">
  <title>OncoKB Card</title>

  <link rel="apple-touch-icon" href="apple-touch-icon.png">
  <!-- Place favicon.ico in the root directory -->

  <!-- build:css styles/vendor.css -->
  <!-- bower:css -->
  <link rel="stylesheet" href="/bower_components/qtip2/jquery.qtip.min.css" />
  <!-- endbower -->
  <!-- endbuild -->

  <!-- build:css styles/main.css -->
  <link rel="stylesheet" href="styles/main.css">
  <!-- endbuild -->
  <!-- build:js scripts/vendor/modernizr.js -->
  <script src="/bower_components/modernizr/modernizr.js"></script>
  <!-- endbuild -->
</head>
<body>
<!--[if lt IE 10]>
<p class="browserupgrade">You are using an <strong>outdated</strong> browser. Please <a href="http://browsehappy.com/">upgrade your browser</a> to improve your experience.</p>
<![endif]-->
<div class="container" id="main">
</div>

<!-- build:js scripts/vendor.js -->
<!-- bower:js -->
<script src="/bower_components/jquery/dist/jquery.js"></script>
<script src="/bower_components/underscore/underscore.js"></script>
<script src="/bower_components/ev-emitter/ev-emitter.js"></script>
<script src="/bower_components/imagesloaded/imagesloaded.js"></script>
<script src="/bower_components/qtip2/jquery.qtip.js"></script>
<script src="/bower_components/qtip2/basic/jquery.qtip.js"></script>
<!-- endbower -->
<!-- endbuild -->

<script src="/bower_components/bootstrap-sass/assets/javascripts/bootstrap.js"></script>

<!-- build:js scripts/main.js -->
<script src="scripts/main.js"></script>
<!-- endbuild -->

<script>
  $(document).ready(function() {
    $('#main').load('template.html', function() {
      _.templateSettings = {
        interpolate : /\{\{(.+?)\}\}/g
      };

      var meta = {
        title: 'BRAF V600E in Melanoma',
        gene: 'BRAF',
        oncogenicity: 'Oncogenic',
//        oncogenicity: '',
        oncogenicityCitations: '',
        mutationEffect: 'Gain-of-function',
//        mutationEffect: '',
//        mutationEffectCitations: '',
        mutationEffectCitations: '12068308,16273091,15035987,15035987,22535154,23051966',
        clinicalSummary: 'BRAF encodes an intracellular kinase and component of the pro-oncogenic MAP-kinase signaling pathway. BRAF is mutated in a diverse range of cancers, including melanoma, thyroid and lung cancer. The BRAF V600K mutation is known to be oncogenic.',
//        biologicalSummary: 'This gain-of-function mutation is the second most commonly found BRAF mutation (second to V600E) and is located in the protein\'s kinase domain (PMID: 12068308, 16273091). BRAF V600K has modestly higher in vitro basal kinase activity compared to the wildtype protein; however, its inherent kinase activity is significantly lower than that of the V600E mutant (PMID: 15035987). Concordant with its higher in vitro activity, BRAF V600K shows a significantly stronger activation of downstream phospho-ERK (pERK) relative to wildtype BRAF (PMID: 15035987). Preliminary experimental evidence suggests that while there may be distinct clinicopathologic features that distinguish V600K from V600E (PMID: 22535154), these two variants appear to respond similarly to MAPK-pathway specific inhibitors (PMID: 23051966).BRAF encodes an intracellular kinase and component of the pro-oncogenic MAP-kinase signaling pathway. BRAF is mutated in a diverse range of cancers, including melanoma, thyroid and lung cancer. The BRAF V600K mutation is known to be oncogenic.',
        biologicalSummary: '',
//        biologicalSummary: undefined,
        treatments: [
          {
            level: '1',
            variant: 'V600E',
            treatment: 'Trametinib',
            cancerType: 'Melanoma',
            citations: '22663011,23846731,25265492,25399551'
          },
//          {
//            level: '1',
//            variant: 'V600K',
//            treatment: 'Dabrafenib',
//            cancerType: 'Melanoma',
//            citations: '22663011,23846731,25265492,25399551'
//          },
//          {
//            level: '1',
//            variant: 'V600E/K',
//            treatment: 'Trametinib + Dabrafenib',
//            cancerType: 'Melanoma',
//            citations: '22663011,23846731,25265492,25399551'
//          },
//          {
//            level: '2A',
//            variant: 'V600E/K',
//            treatment: 'Trametinib + Dabrafenib',
//            cancerType: 'Melanoma/Non-Small Cell Lung Cancer',
//            citations: '22663011,23846731,25265492,25399551'
//          }
          // {
          //   level: '3A',
          //   variant: 'V600E',
          //   treatment: 'Vemurafenib',
          //   cancerType: 'Melanoma',
          //   citations: '22663011,23846731,25265492,25399551'
          // },
          // {
          //   level: '3B',
          //   variant: 'V600E/K',
          //   treatment: 'Vemurafenib+Cobimetinib',
          //   cancerType: 'Melanoma',
          //   citations: ''
          // },
          // {
          //   level: '4',
          //   variant: 'V600E',
          //   treatment: 'Cobimetinib',
          //   cancerType: 'Melanoma',
          //   citations: ''
          // },
          // {
          //   level: 'R1',
          //   variant: 'V600E',
          //   treatment: 'Cobimetinib',
          //   cancerType: 'Melanoma',
          //   citations: '22663011,23846731,25265492,25399551'
          // },
        ]
      };
      OncoKBCard.init(meta, "#main");
    });
  })
</script>
</body>
</html>
